ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 6,770,000 shares, a growth of 13.8% from the December 15th total of 5,950,000 shares. Currently, 14.6% of the company's shares are short sold. Based on an average daily trading volume, of 5,090,000 shares, the days-to-cover ratio is presently 1.3 days.
ASP Isotopes stock opened at $5.66 on Friday. The stock's 50-day moving average is $5.51 and its 200-day moving average is $4.08. The company has a market cap of $404.07 million, a price-to-earnings ratio of -9.28 and a beta of 3.48. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. ASP Isotopes has a 12 month low of $1.86 and a 12 month high of $9.33.
Several equities analysts recently weighed in on ASPI shares. Canaccord Genuity Group reiterated a "buy" rating and set a $4.50 target price on shares of ASP Isotopes in a research report on Friday, October 18th. Canaccord Genuity Group started coverage on ASP Isotopes in a research report on Friday, October 4th. They set a "buy" rating and a $4.50 target price on the stock.
Check Out Our Latest Analysis on ASPI
A number of large investors have recently modified their holdings of the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in shares of ASP Isotopes in the 3rd quarter worth about $6,249,000. Telemark Asset Management LLC acquired a new stake in shares of ASP Isotopes in the third quarter valued at about $4,726,000. Geode Capital Management LLC grew its stake in shares of ASP Isotopes by 42.7% in the third quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company's stock valued at $3,110,000 after buying an additional 334,836 shares in the last quarter. Philadelphia Financial Management of San Francisco LLC grew its stake in shares of ASP Isotopes by 158.3% in the third quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company's stock valued at $2,757,000 after buying an additional 607,893 shares in the last quarter. Finally, State Street Corp grew its stake in shares of ASP Isotopes by 12.8% in the third quarter. State Street Corp now owns 853,695 shares of the company's stock valued at $2,373,000 after buying an additional 96,604 shares in the last quarter. 16.80% of the stock is currently owned by hedge funds and other institutional investors.
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ASP Isotopes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.
While ASP Isotopes currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.